Advertisement
Advertisement

ASMB

ASMB logo

Assembly Biosciences, Inc

27.96
USD
Sponsored
+1.00
+3.71%
Jun 30, 15:18 UTC -4
Open

ASMB Earnings Reports

Positive Surprise Ratio

ASMB beat 27 of 39 last estimates.

69%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$8.77M
/
-$0.63
Implied change from Q1 26 (Revenue/ EPS)
+6.79%
/
+16.67%
Implied change from Q2 25 (Revenue/ EPS)
-8.88%
/
-52.63%

Assembly Biosciences, Inc earnings per share and revenue

On May 07, 2026, ASMB reported earnings of -0.54 USD per share (EPS) for Q1 26, beating the estimate of -0.58 USD, resulting in a 7.12% surprise. Revenue reached 8.21 million, compared to an expected 9.45 million, with a -13.10% difference. The market reacted with a -3.85% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.63 USD, with revenue projected to reach 8.77 million USD, implying an increase of 16.67% EPS, and increase of 6.79% in Revenue from the last quarter.
FAQ
For Q1 2026, Assembly Biosciences, Inc reported EPS of -$0.54, beating estimates by 7.12%, and revenue of $8.21M, -13.1% below expectations.
The stock price moved down -3.85%, changed from $30.93 before the earnings release to $29.74 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 4 analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.63 and revenue of $8.77M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement